Trial Profile
A Randomized Feasibility Study of Letrozole in Postmenopausal Women at Increased Risk for Development of Breast Cancer as Evidenced by High Breast Density.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Letrozole (Primary)
- Indications Early breast cancer
- Focus Pharmacodynamics; Therapeutic Use
- 01 Apr 2010 Results have been published in Breast Cancer Research and Treatment.
- 16 Jan 2010 Planned end date (9 Jun 2006) added from National Cancer Institute of Canada record.
- 12 Sep 2008 Added ID and trial centre, from National Cancer Institute of Canada record.